Hematology

Filter

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

February 2026

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

Diana Web, Institut Cochin in Paris

Hema Now: Episode 29: Inside the Tumour Microenvironment

How do leukaemic cells invade the central nervous system?

chemotherapy

ASAP Trial Finds No Benefit for Pre-Transplant Chemotherapy in AML

The ASAP trial shows immediate transplantation matches chemotherapy outcomes in AML, with genetics driving survival differences.

blood stem cell

Study Uncovers Key Role of P-Selectin in Ageing Blood Stem Cells

Researchers identify P-selectin as key driver of blood stem cell ageing and inflammation-linked decline.

Serum-free light chain

Serum-Free Light Chains Enhance Myeloma Monitoring

Serum-free light chain testing enables earlier, more accurate tracking of multiple myeloma treatment response and disease progression.

delays

Delayed CAR-T Cell Therapy Worsens Survival

Delays between cell collection and infusion significantly lower survival rates for lymphoma patients receiving CAR T-cell therapy.

Patient and physician perspectives on shared decisions in CML

In this new podcast episode, Lisa Machado, a patient advocate diagnosed with CML in 2008 and clinician and CML expert Jeffrey Lipton, sit…

New Study Links Systemic Sclerosis to Higher Cancer Risk

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

Pieter Sonneveld

Hema Now: Episode 28: Charting a New Era in Myeloma Care

What breakthroughs are redefining multiple myeloma treatment and patient outcomes?

Loading posts...

« Previous 1 … 4 5 6 7 8 … 100 Next »